HR 941 117th Congress

TRANSPLANT Act of 2021

Latest Action

Became Public Law No: 117-15.

Congress.gov

Sponsors

Rep. Matsui, Doris O. [D-CA-6]

Rep. Matsui, Doris O. [D-CA-6]

D — CA

Summary

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.

Vote Result

Passed House

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)

Actions

2021-05-26T00:00:00

Became Public Law No: 117-15.

2021-05-26T00:00:00

Became Public Law No: 117-15.

2021-05-26T00:00:00

Signed by President.

2021-05-26T00:00:00

Signed by President.

2021-05-20T00:00:00

Presented to President.

2021-05-20T00:00:00

Presented to President.

2021-05-18T00:00:00

Message on Senate action sent to the House.

2021-05-17T00:00:00

Passed Senate without amendment by Voice Vote.

2021-05-17T00:00:00

Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.

2021-05-17T00:00:00

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)

2021-05-17T00:00:00

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)

2021-04-19T00:00:00

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2021-04-15T00:00:00

Motion to reconsider laid on the table Agreed to without objection.

2021-04-15T00:00:00

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)

2021-04-15T00:00:00

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109).(text: 04/14/2021 CR H1752-1753)

2021-04-15T00:00:00

Considered as unfinished business. (consideration: CR H1829)

2021-04-14T00:00:00

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

2021-04-14T00:00:00

DEBATE - The House proceeded with forty minutes of debate on H.R. 941.

2021-04-14T00:00:00

Considered under suspension of the rules. (consideration: CR H1752-1754)

2021-04-14T00:00:00

Mr. Pallone moved to suspend the rules and pass the bill.

2021-02-09T00:00:00

Referred to the Subcommittee on Health.

2021-02-08T00:00:00

Referred to the House Committee on Energy and Commerce.

2021-02-08T00:00:00

Introduced in House

2021-02-08T00:00:00

Introduced in House

Policy Areas

Health

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play